This consultation closed on 6 September 2022
The APVMA is considering an application for registration of the product Method 240 SL Herbicide, a soluble concentrate (SL) formulation containing 240 g/L of the approved active constituent, aminocyclopyrachlor. The product is intended for the control of woody weeds and other invasive weed species in native conservation areas, pastoral grazing land and industrial sites such as railways, roadways, and utility rights-of-way.
We invite comment from 9 August 2022 to 6 September 2022 on whether registration of the product should be granted. The APVMA is able to consider comments relating to the legislative grounds, including:
- occupational health and safety
- public health
- chemistry and manufacture
- residues in food
- efficacy and target crop safety.
Download the Public Release Summary on the evaluation of Method 240 SL Herbicide.
For more information see page 28, APVMA Gazette No. 16, 9 August 2022.
Please note: submissions will be published on the APVMA’s website, unless you have asked for the submission to remain confidential, or if the APVMA chooses at its discretion not to publish any submissions received (refer to the public consultation coversheet).
Please lodge your submission using the public consultation coversheet, which provides options for how your submission will be published.
Note that all APVMA documents are subject to the access provisions of the Freedom of Information Act 1982 and may be required to be released under that Act should a request for access be made.
Please send your written submission and coversheet by email or post to:
Post:
Case Management and Administration Unit
Australian Pesticides and Veterinary Medicines Authority
GPO Box 3262
Sydney NSW 2001
Telephone: +61 2 6770 2300
Email: casemanagement@apvma.gov.au
Submissions received
The APVMA sought comments from interested stakeholders on aminocyclopyrachlor in the product Method 240 SL Herbicide, in a consultation that closed on 6 September 2022.
One submission was received from an industry body.
Consultation feedback
We have completed our review of the submission and finalised registration of the product.